Literature DB >> 1931721

Analysis of lung asbestos content.

A Churg.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1931721      PMCID： PMC1012053          DOI： 10.1136/oem.48.10.649

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN： 0007-1072


× No keyword cloud information.
  23 in total

1.  Mesothelioma in Cyprus: the role of tremolite.

Authors:  K McConnochie; L Simonato; P Mavrides; P Christofides; F D Pooley; J C Wagner
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

2.  Lung dust analysis in the assessment of past exposure of man-made mineral fibre workers.

Authors:  J C McDonald; B W Case; P E Enterline; V Henderson; A D McDonald; M Plourde; P Sébastien
Journal:  Ann Occup Hyg       Date:  1990-10

3.  Fiber size and number in workers exposed to processed chrysotile asbestos, chrysotile miners, and the general population.

Authors:  A Churg; B Wiggs
Journal:  Am J Ind Med       Date:  1986       Impact factor: 2.214

4.  Lung asbestos content in long-term residents of a chrysotile mining town.

Authors:  A Churg
Journal:  Am Rev Respir Dis       Date:  1986-07

5.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

6.  Mineralogic parameters related to amosite asbestos-induced fibrosis in humans.

Authors:  A Churg; J Wright; B Wiggs; L Depaoli
Journal:  Am Rev Respir Dis       Date:  1990-12

7.  Correlation between fibre content of the lung and disease in east London asbestos factory workers.

Authors:  J C Wagner; M L Newhouse; B Corrin; C E Rossiter; D M Griffiths
Journal:  Br J Ind Med       Date:  1988-05

8.  Lung asbestos content in chrysotile workers with mesothelioma.

Authors:  A Churg; B Wiggs; L Depaoli; B Kampe; B Stevens
Journal:  Am Rev Respir Dis       Date:  1984-12

9.  The hygiene standard for chrysotile asbestos.

Authors:  J Peto
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

Review 10.  Human disease consequences of fiber exposures: a review of human lung pathology and fiber burden data.

Authors:  V L Roggli
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031
View more
  7 in total

1.  Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region.

Authors:  D Howel; A Gibbs; L Arblaster; L Swinburne; M Schweiger; E Renvoize; P Hatton; F Pooley
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

2.  Electron microscopic microanalysis of bronchoalveolar lavage: a way to identify exposure to silica and silicate dust.

Authors:  E Monsó; A Carreres; J M Tura; J Ruiz; J Fiz; C Xaus; M Llatjós; J Morera
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

Review 3.  Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2019-09-19       Impact factor: 5.913

Review 4.  Mesothelioma: cases associated with non-occupational and low dose exposures.

Authors:  G Hillerdal
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

5.  Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study.

Authors:  C Magnani; F Mollo; L Paoletti; D Bellis; P Bernardi; P Betta; M Botta; M Falchi; C Ivaldi; M Pavesi
Journal:  Occup Environ Med       Date:  1998-12       Impact factor: 4.402

Review 6.  Risk assessment of oxidant gases and particulate air pollutants: uncertainties and research needs.

Authors:  J M Samet; W E Pepelko; B Sonawane; G E Hatch; K E Driscoll; G Oberdörster
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

Review 7.  Epidemiological significance of mineral fiber persistence in human lung tissue.

Authors:  J C McDonald
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.